Cardiac Surgery Devices Market to Reach USD 2.5 Billion by 2034 at a 3.7% of CAGR, Amid Rising Cardiac Procedures

The global cardiac surgery devices market is poised for steady growth, with its valuation expected to reach USD 2.5 billion by 2034, expanding at a CAGR of 3.7% from 2024 to 2034. In 2024, the market is estimated to be worth USD 1.8 billion, driven by the increasing prevalence of cardiovascular diseases and advancements in surgical technology. As cardiac procedures become more sophisticated and accessible, the demand for high-quality surgical devices is set to rise.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰: https://www.futuremarketinsights.com/report-sample#5245502d47422d34363032

The surge in cardiac disorders, including coronary artery disease, heart valve complications, and congenital heart defects, has led to a growing reliance on minimally invasive and robotic-assisted surgeries. Technological advancements, such as artificial heart valves, improved perfusion systems, and advanced imaging techniques, are enhancing surgical precision and patient outcomes. The increasing adoption of these innovations is significantly contributing to market expansion.

Furthermore, rising healthcare expenditures, an aging population, and a global increase in lifestyle-related cardiac conditions are key factors influencing market growth. Governments and healthcare organizations are investing in improved cardiovascular care infrastructure, further fueling the demand for advanced surgical devices. Leading medical device companies are focusing on R&D to introduce next-generation cardiac surgery solutions, catering to the evolving needs of surgeons and patients.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬

The cardiac surgery devices market is projected to reach USD 2.5 billion by 2034, growing at a CAGR of 3.7%.

Rising prevalence of cardiovascular diseases is driving demand for innovative surgical solutions.

Technological advancements, including robotic-assisted and minimally invasive procedures, are enhancing surgical outcomes.

Increased healthcare investments and an aging population are contributing to steady market growth.

𝐓𝐫𝐞𝐧𝐝𝐬:

Minimally Invasive Surgeries: Minimally invasive surgeries like transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR) are becoming more popular due to their lower risks and reduced recovery times. These techniques are replacing conventional surgeries, prompting market players to upgrade their devices1.
Increasing Cardiovascular Disorders: The surge in chronic cardiovascular disorders contributes to market growth. Cardiovascular diseases (CVDs) are the primary global cause of mortality, claiming approximately 17.9 million lives yearly.
Technological Advancements: Advancements in technology have transformed how patients and medical professionals approach cardiac surgeries1.
Structural Heart Devices: The global structural heart devices market was valued at US$13.75 billion in 2023 and is expected to reach US$22.16 billion by 2029, growing at a CAGR of 8.28%. These devices are designed for the diagnosis and treatment of structural abnormalities within the heart.

𝐀 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 : https://www.futuremarketinsights.com/reports/cardiac-surgery-devices-market

𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐤𝐞𝐲 𝐝𝐫𝐢𝐯𝐞𝐫𝐬 𝐛𝐞𝐡𝐢𝐧𝐝 𝐭𝐡𝐞 𝐠𝐫𝐨𝐰𝐭𝐡 𝐨𝐟 𝐭𝐡𝐞 𝐜𝐚𝐫𝐝𝐢𝐚𝐜 𝐬𝐮𝐫𝐠𝐞𝐫𝐲 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭?

The key drivers behind the growth of the cardiac surgery devices market are:

Increasing Prevalence of Cardiovascular Diseases (CVDs): The rising incidence of CVDs, including coronary artery disease, heart failure, and arrhythmia, is a primary driver. Factors contributing to this increase include sedentary lifestyles, unhealthy diets, rising stress levels, and the aging population. CVDs are the leading cause of death worldwide.

Aging Population: As the global population ages, the prevalence of cardiovascular diseases increases, leading to a higher demand for cardiac surgery devices. Individuals over 60 are more prone to chronic ailments, including cardiovascular diseases.

Technological Advancements: Advancements in technology have transformed how patients and medical professionals approach cardiac surgeries. Developments in medical device technology are boosting the industry's expansion.

Minimally Invasive Surgeries: There is a growing preference for minimally invasive surgeries like transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR) due to their lower risks, reduced recovery times, and suitability, especially among the elderly4. This trend prompts market players to upgrade their devices4.

Government Initiatives and R&D Investments: Government initiatives for increased R&D investments and awareness campaigns among people for cardiac health risks are fueling market growth. Public and private healthcare facilities generate demand for these devices, with governments in developing economies investing in these devices to include economically deprived populations.

Increasing Demand for Interventional Cardiology Procedures: The rising demand for interventional cardiology procedures, including stenting, angioplasty, and transcatheter valve replacement, fuels the need for cardiovascular devices.

Expansion in Emerging Economies: The interventional cardiology device market is expanding rapidly in emerging economies in Asia-Pacific, Latin America, and the Middle East due to increasing cases of cardiovascular diseases, increased awareness of advanced treatment options, and increased healthcare spending.

Obesity Rates: Rising obesity rates worldwide are a significant driver for cardiac surgeries. Individuals with obesity are nearly three times more likely to develop type 2 diabetes, increasing the demand for cardiac interventions and devices.

𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜 𝐃𝐞𝐯𝐢𝐜𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬: 𝐊𝐞𝐲 𝐓𝐫𝐞𝐧𝐝𝐬, 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐫𝐨𝐣𝐞𝐜𝐭𝐢𝐨𝐧𝐬 & 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐀𝐜𝐫𝐨𝐬𝐬 𝟏𝟓+ 𝐂𝐨𝐮𝐧𝐭𝐫𝐢𝐞𝐬 - https://www.futuremarketinsights.com/industry-analysis/therapeutic-device

𝐏𝐫𝐨𝐦𝐢𝐧𝐞𝐧𝐭 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐌𝐚𝐫𝐤𝐞𝐭

Abbott Laboratories
Medtronic Plc.
Boston Scientific Corporation
Johnson & Johnson (Ethicon)
B. Braun Melsungen AG
Terumo Corporation
LivaNova PLC
Edwards Lifesciences Corporation
Cardinal Health
Stryker Corporation
Cook Medical
Philips Healthcare
Getinge Group
Hologic, Inc.
AtriCure, Inc.
Lepu Medical Technology Co. Ltd.
C.R. Bard (now part of BD)
Zoll Medical Corporation
Merit Medical Systems, Inc.
Asahi Intecc Co., Ltd.

𝐂𝐚𝐫𝐝𝐢𝐚𝐜 𝐒𝐮𝐫𝐠𝐞𝐫𝐲 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

By Product:

Referring to the cardiac surgery devices industry analysis, the market is segmented into heart lung machine, breathing heart surgery systems, catheters, perfusion disposables, etc.

By Procedure:

On the basis of procedures, the market is segmented into coronary artery bypass grafting and minimally invasive surgeries.

By End-users:

Sector analysis suggests that the market is segmented into hospitals and ambulatory surgical centers on the basis of end-users.

By Region:

The market can be segmented by region, encompassing North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐅𝐌𝐈'𝐬 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐎𝐧𝐠𝐨𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐃𝐨𝐦𝐚𝐢𝐧:

Electrosurgery Generators Industry Outlook from 2025 to 2035 -https://www.futuremarketinsights.com/reports/electrosurgery-generators-market

Electrosurgery Devices Market Outlook - https://www.futuremarketinsights.com/reports/electrosurgery-devices-market

General Surgery Devices Market Snapshot - https://www.futuremarketinsights.com/reports/general-surgery-devices-market

Cardiac Rhythm Management Market Outlook for 2024 to 2034 -https://www.futuremarketinsights.com/reports/cardiac-rhythm-management-market

Cardiac Rehabilitation Market Outlook from 2024 to 2034 -https://www.futuremarketinsights.com/reports/cardiac-rehabilitation-market

Cardiac Biomarker Diagnostic Test Kits Market Outlook from 2023 to 2033 -https://www.futuremarketinsights.com/reports/cardiac-bio-marker-diagnostic-test-market

Cardiac Rhythm Remote Monitoring Devices Market Outlook (2023 to 2033) -https://www.futuremarketinsights.com/reports/cardiac-rhythm-remote-monitoring-devices-market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

This release was published on openPR.